The Genetic Basis of Inherited Neurologic Deficits in People With Schizophrenia
NCT00247637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2025
Last updated 2013-07-03
Summary
This is a study of the genetic basis of brain dysfunction in people with schizophrenia.
Conditions
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
University of California, San Diego
lead OTHER
Principal Investigators
-
David Braff, MD · University of California, San Diego
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-05-31
- Primary Completion
- 2008-09-30
- Completion
- 2008-09-30
Countries
- United States
Study Locations
More Related Trials
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
NCT02205437 ·Status: UNKNOWN
-
Emotion Endophenotypes in Schizophrenia
NCT02834208 ·Status: UNKNOWN ·Phase: NA
-
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535 ·Status: COMPLETED
-
Oculomotor and Spatial Cognition Deficits in Schizophrenia
NCT00931996 ·Status: TERMINATED ·Phase: NA
-
Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia
NCT01399437 ·Status: COMPLETED
-
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia
NCT04655235 ·Status: RECRUITING
-
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
NCT00178932 ·Status: COMPLETED ·Phase: NA
-
Familial Schizophrenia and Spectrum Personality Disorders
NCT00666146 ·Status: COMPLETED
-
Schizophrenia Imaging
NCT01655472 ·Status: UNKNOWN ·Phase: NA
-
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia
NCT02237235 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of a Clinical Screening Grid for Syndromic Schizophrenia
NCT02746510 ·Status: TERMINATED ·Phase: NA
-
Schizophrenia and Genetic Counseling
NCT00111202 ·Status: UNKNOWN
-
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
NCT07162467 ·Status: ENROLLING_BY_INVITATION
-
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323 ·Status: COMPLETED
-
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Family Study in Schizophrenia
NCT00418912 ·Status: UNKNOWN
-
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
NCT06700967 ·Status: NOT_YET_RECRUITING
-
fMRI Cholinergic Mechanisms in Schizophrenia
NCT01191827 ·Status: COMPLETED
-
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
NCT06886945 ·Status: RECRUITING
-
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders
NCT03166098 ·Status: COMPLETED
-
Prospective Studies of the Pathogenesis of Schizophrenia
NCT00877552 ·Status: COMPLETED
-
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
NCT03068806 ·Status: COMPLETED
-
the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder.
NCT02565524 ·Status: COMPLETED ·Phase: NA